Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RHIZ'ART: Hyaluronic Acid and Corticosteroids in Rhizarthrosis
NCT03431584Phase 4Completed
- Sponsor
- CHD Vendée
- Start
- May 2018
- Primary completion
- May 2021
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of hyaluronic acid in Rhizarthrosis, sponsored by CHD Vendée. Started May 2018; status: completed.
02
Drugs
hyaluronic acid
03
Conditions
Rhizarthrosis
Beyond the preview
Go deeper on NCT03431584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03431584.